# The Impact of Inhalation vs Total Intravenous Anesthesia on the Immune Status and Mortality in Patients Undergoing Breast Cancer Surgery: a Prospective Double-Blind Randomized Clinical Trial.

> **NCT04800393** · NA · RECRUITING · sponsor: **Moscow Clinical Scientific Center** · enrollment: 130 (estimated)

## Conditions studied

- Anesthesia
- Breast Cancer

## Interventions

- **DRUG:** Sevoflurane
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT04800393
- **Lead sponsor:** Moscow Clinical Scientific Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-29
- **Primary completion:** 2023-07-01
- **Final completion:** 2028-04-01
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2023-04-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04800393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04800393, "The Impact of Inhalation vs Total Intravenous Anesthesia on the Immune Status and Mortality in Patients Undergoing Breast Cancer Surgery: a Prospective Double-Blind Randomized Clinical Trial.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04800393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*